ORPHA:653698
Lymphocytic mastitis
Also known as: Lymphocytic mastopathy · Sclerosing lymphocytic lobulitis
Publications
350
72.6th percentile
Trials
0
Interventional, condition-specific
Researchers
1,031
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
350 matched papers (141 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
350
350 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
350 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
141 in the last 10 years · high confidence · 72.6th percentile (publications denominator)
Phrase hits: 350 · MeSH hits: 0
Who's working on it?
1,031
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Hirschfield GM4 papers · 2025
Dr Onofrio is a hepatology fellow in the Division of Gastroenterology at the University of Toronto and the Toronto Centre for Liver Disease at Toronto General Hospital in the University Health Network in Toronto, Canada. Dr Hirschfield is the Lily and Terry Horner Chair in Autoimmune Liver Disease Research in the Toronto Centre for Liver Disease at Toronto General Hospital and a professor of medicine in the Division of Gastroenterology at the University of Toronto. Dr Gulamhusein is an assistant professor at the University of Toronto and a clinician investigator in the Division of Gastroenterology in the Toronto Centre for Liver Disease at Toronto General Hospital.
Papers in Europe PMC - 02Liu H4 papers · 2026
Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Papers in Europe PMC - 03Choi SJ3 papers · 2025
Department of Pathology, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
Papers in Europe PMC - 04Theaker JM3 papers · 2006Papers in Europe PMC
- 05Arifi N2 papers · 2025Papers in Europe PMC
- 06Bayar S2 papers · 2025Papers in Europe PMC
- 07Bhardwaj M2 papers · 2024
Department of Veterinary Microbiology, College of Veterinary Science, CSK Himachal Pradesh Agriculture University, Palampur, Himachal Pradesh-176062, India.
Papers in Europe PMC - 08Casulari LA2 papers · 2010Papers in Europe PMC
- 09Chan JK2 papers · 2009Papers in Europe PMC
- 10Chen B2 papers · 2025
The Autoimmune and Rare Liver Disease Programme, Division of Gastroenterology and Hepatology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Lymphocytic mastitis" OR "Lymphocytic mastopathy" OR "Sclerosing lymphocytic lobulitis"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Lymphocytic mastitis" OR "Lymphocytic mastopathy" OR "Sclerosing lymphocytic lobulitis"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T19:57:56.763Z